Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MDM4 | O15151 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26160451 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446045 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29401309 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29564442 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL119043 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29349978 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL178736 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29508222 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446029 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL119044 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122068110-A | Amino acid type supermolecule gel polymer electrolyte and preparation method and application thereof | 四川荣创新能动力系统有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-120058855-A | Preparation method of Mebamamide C | 深圳连续制药科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-113929751-B | Preparation method of ganirelix acetate | 深圳翰宇药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-114524860-B | ETELCALCETIDE synthesis method and application thereof | 深圳翰宇药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118812662-A | Method for preparing ganirelix acetate | 杭州昊肽生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115541734-B | Method for measuring protected amino acid enantiomer by normal phase chromatography | 南京锐志生物医药有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-114920804-B | Cetrorelix synthesis process capable of being directly used for pilot scale amplification | 厦门胜泽泰医药科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-117924431-A | Natural cyclopeptide zelkovamycins simplified substance and preparation method and application thereof | 北流市中医医院 | 2024-04-26 | — | — | CN | claimed |
| CN-117069794-B | Glycopeptide antibiotic fluorescent probe compound and preparation method and application thereof | 广州中医药大学(广州中医药研究院) | 2024-02-13 | — | — | CN | claimed |
| CN-116947966-B | Method for preparing itracin intermediate and itracin | 哈药集团生物工程有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116041441-A | Synthesis method of daptomycin | 申联生物医药（上海）股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-112876541-B | Solid-phase synthesis method of degarelix | 深圳翰宇药业股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-115541734-A | Method for determining protected amino acid enantiomer by normal phase chromatography | 南京锐志生物医药有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115490756-A | Method for preparing eptifibatide by solid-liquid phase combination | 深圳市健翔生物制药有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-114920804-A | Sitrorelix synthesis process capable of being directly used for pilot amplification | 厦门胜泽泰医药科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-114478708-A | Solid phase synthesis method of ganirelix fragment | 南京汉欣医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20220143150-A1 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | ENZENE BIOSCIENCES LIMITED (IN) | 2022-05-12 | — | — | US | claimed |
| CN-112062811-B | Synthetic method of vilacatide | 深圳翰宇药业股份有限公司 | 2022-03-25 | — | — | CN | claimed |
| WO-2022044030-A1 | AN IMPROVED PROCESS FOR FMOC SYNTHESIS OF ETELCALCETIDE | USV PRIVATE LIMITED (IN) | 2022-03-03 | — | — | WO | claimed |
| EP-3941936-A2 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | Enzene Biosciences Ltd. (IN) | 2022-01-26 | — | — | EP | claimed |